Effect of isosorbide dinitrate on cardiac output in severe cardiac failure: Relation to initial hemodynamics, ventricular volume, and the preload reserve mechanism

Isosorbide dinitrate (ISDN) improves the clinical and hemodynamic state of patients with heart failure, but may cause dizziness and syncope. To characterize patients in whom cardiac output falls with high‐dose nitrate therapy and to examine further the pathophysiology of the fall in cardiac output in these patients, we studies the effect of sublingual ISDN on forward cardiac output in 14 patients with severe cardiac failure (New York Heart Association grades 3–4). We examined systolic and diastolic left ventricular (LV) function from pressure and volume analyses of LV function. After administration of 15 mg ISDN, cardiac output was either unaltered or increased in 7 patients (Group 1) (11±12%, mean±SD), and decreased in 7 (Group 2) (‐13±10%) (Group 1 vs. 2, p<0.002). Initial systemic arterial pressure, LV ejection fraction, wedge and LV transmural filling pressures were similar in both groups, but Group 2 patients had a lower systemic vascular resistance (p=0.07) and tended to have a larger initial LV end‐diastolic volume and increased end‐diastolic compliance; following ISDN the decrease in LV filling pressure and end‐diastolic volume was larger and the product of the changes greater (p<0.02). Thus ISDN decreases filling pressure and improves forward cardiac output in some patients with congestive heart failure, but large doses may decrease cardiac output in a subset of patients who have a lower systemic vascular resistance and a larger more compliant ventricle, maintaining forward blood flow predominantly by a preload reserve mechanism. As a simple clinical guide, cardiac output is likely to fall when the wedge pressure is reduced to < 10 mmHg.